Upgrade to SI Premium - Free Trial

Aurinia Pharmaceuticals (AUPH)

15.24 -0.09 (0.59%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Aurinia starts Phase 4 study combining Lupkynis with other lupus drugs July 6, 2026 8:03 AM - StreetInsider Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis July 6, 2026 8:00 AM - BizWire Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Johnson Craig A June 8, 2026 4:14 PM - SEC Filing Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Goetz Kathleen June 8, 2026 4:12 PM - SEC Filing Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Nova Tina Susan June 8, 2026 4:11 PM - SEC Filing Form 4 Aurinia Pharmaceuticals For: Jun 04 Filed by: Bailey Jeffrey Allen June 8, 2026 4:09 PM - SEC Filing Form 144 Aurinia Pharmaceuticals Filed by: Keenan Greg June 5, 2026 4:28 PM - SEC Filing Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: TANG CAPITAL MANAGEMENT LLC June 4, 2026 6:45 PM - SEC Filing Form 8-K Aurinia Pharmaceuticals For: Jun 03 June 4, 2026 4:19 PM - SEC Filing Form 144 Aurinia Pharmaceuticals Filed by: Keenan Greg June 4, 2026 4:12 PM - SEC Filing LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death June 4, 2026 7:00 AM - BizWire Form 4 Aurinia Pharmaceuticals For: May 29 Filed by: TANG KEVIN June 2, 2026 9:55 PM - SEC Filing Form 144 Aurinia Pharmaceuticals Filed by: Keenan Greg June 2, 2026 4:14 PM - SEC Filing Form 4 Aurinia Pharmaceuticals For: May 18 Filed by: Robertson Stephen P. May 20, 2026 5:05 PM - SEC Filing Form 4 Aurinia Pharmaceuticals For: May 18 Filed by: Hearne Michael S May 20, 2026 5:05 PM - SEC Filing Form 4 Aurinia Pharmaceuticals For: May 18 Filed by: Cole Ryan May 20, 2026 5:04 PM - SEC Filing Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences May 19, 2026 8:37 AM - StreetInsider Form 144 Aurinia Pharmaceuticals Filed by: Greenleaf Peter May 11, 2026 4:12 PM - SEC Filing Form 144 Aurinia Pharmaceuticals Filed by: Donley Matthew Maxwell May 11, 2026 4:11 PM - SEC Filing Form 144 Aurinia Pharmaceuticals Filed by: Miller Joseph M May 11, 2026 4:09 PM - SEC Filing Form 8-K Aurinia Pharmaceuticals For: May 08 May 11, 2026 9:21 AM - SEC Filing Form 10-Q Aurinia Pharmaceuticals For: Mar 31 May 7, 2026 8:24 AM - SEC Filing Form 8-K Aurinia Pharmaceuticals For: May 07 May 7, 2026 8:22 AM - SEC Filing Aurinia Pharmaceuticals (AUPH) Tops Q1 EPS by 6c ; Offers Guidance May 7, 2026 8:03 AM - StreetInsider Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress May 7, 2026 8:00 AM - BizWire Full Article List